The DOI matches its Crossref record; 455 of the 455 references it cites were found in a registry or an index.
Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections
Open accessAbstract
ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) are among the most common opportunistic pathogens in nosocomial infections. ESKAPE pathogens distinguish themselves from normal ones by developing a high level of antibiotic resistance that involves multiple mechanisms. Contemporary therapeutic strategies which are potential options in combating ESKAPE bacteria need further investigation. Herein, a broad overview of the antimicrobial research on ESKAPE pathogens over the past five years is provided with prospective clinical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–455 of 455
Pandey, S., Li, L., Deng, X. Y., Cui, D. M., & Gao, L. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2018.01174 · Cited by 33
Inhibition of bacterial toxin recognition of membrane components as an anti-virulence strategy
Krueger, E. E., & Brown, A. C. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-018-0138-z · Cited by 33
Mendes, R. E., Castanheira, M., Woosley, L. N., Stone, G. G., Bradford, P. A., & Flamm, R. K. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.04.001 · Cited by 32
Geethalakshmi, R., Sundaramurthi, J. C., & Sarada, D. V. L. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.05.016 · Cited by 32
Nasirmoghadas, P., Yadegari, S., Moghim, S., Esfahani, B. N., Fazeli, H., Poursina, F., Hosseininassab, S. A., & Safaei, H. G. (2018) · Advanced Biomedical Research · doi:10.4103/abr.abr_37_17 · Cited by 32
Rogers, S. A., Lindsey, E. A., Whitehead, D. C., Mullikin, T. C., & Melander, C. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.057 · Cited by 31
Talan, D. A., LoVecchio, F., Abrahamian, F. M., Karras, D. J., Steele, M. T., Rothman, R. E., Krishnadasan, A., Mower, W. R., Hoagland, R. J., & Moran, G. J. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw177 · Cited by 31
Joachim, A., Moyo, S. J., Nkinda, L., Majigo, M. V., Rugarabamu, S., Mkashabani, E. G., Mmbaga, E. J., Mbembati, N., Aboud, S., & Lyamuya, E. (2018) · International Journal of Microbiology · doi:10.1155/2018/5058390 · Cited by 31
Systematic characterization of position one variants within the lantibiotic nisin
Lagedroste, M., Reiners, J., Smits, S. H. J., & Schmitt, L. (2019) · Scientific Reports · doi:10.1038/s41598-018-37532-4 · Cited by 31
Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria
Barker, W. T., Chandler, C. E., Melander, R. J., Ernst, R. K., & Melander, C. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.03.019 · Cited by 31
Tadić, V., Oliva, A., Božović, M., Cipolla, A., Angelis, M. D., Vullo, V., Garzoli, S., & Ragno, R. (2017) · Molecules · doi:10.3390/molecules22091395 · Cited by 30
An evaluation of tedizolid for the treatment of MRSA infections
Hall, R. G., Smith, W. J., Putnam, W. C., et al. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1519021 · Cited by 30
Omadacycline — The Newest Tetracycline
Chambers, H. F. “. (2019) · New England Journal of Medicine · doi:10.1056/nejme1900188 · Cited by 30
Ayed, H. B., Koubâa, M., Hammami, F., Marrakchi, C., Rekik, K., Jemaa, T. B., Maâloul, I., Yaïch, S., Dammak, J., & Jemâa, M. B. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz103 · Cited by 30
Beringer, P. M., Bensman, T. J., Ho, H., Agnello, M., Denovel, N., Nguyen, A., Wong‐Beringer, A., She, R. C., Tran, D. Q., Moskowitz, S. M., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv301 · Cited by 29
Ngo, H., Shrestha, S. K., Green, K. D., & Garneau‐Tsodikova, S. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.060 · Cited by 29
Taşlı, H., Akbıyık, A., Topaloğlu, N., Alptüzün, V., & Parlar, S. (2018) · The Journal of Microbiology · doi:10.1007/s12275-018-8244-7 · Cited by 29
Poovelikunnel, T. T., Gethin, G., Solanki, D., McFadden, E., Codd, M., & Humphreys, H. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.10.016 · Cited by 28
Nazir, A. (2019) · Journal of Laboratory Physicians · doi:10.4103/jlp.jlp_129_18 · Cited by 28
Toxicological Concerns of Engineered Nanosize Drug Delivery Systems
Mukherjee, B., Maji, R., Roychowdhury, S., & Ghosh, S. (2013) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000433947.16654.75 · Cited by 27
Bensman, T. J., Jayne, J. G., Sun, M., Kimura, E. M., Meinert, J., Wang, J. C., Schaal, J. B., Tran, D., Rao, A. P., Akbari, O., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00154-17 · Cited by 26
Thomsen, T. T., Mojsoska, B., Cruz, J. C. S., Donadio, S., Jenssen, H., Løbner‐Olesen, A., & Rewitz, K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02965-15 · Cited by 25
Equils, O., da Costa, C., Wible, M., & Lipsky, B. A. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1779-5 · Cited by 25
Saleh, K., Sonesson, A., Persson, K., Riesbeck, K., & Schmidtchen, A. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.07.020 · Cited by 25
High Levels of Cyclic Di-GMP in Klebsiella pneumoniae Attenuate Virulence in the Lung
Rosen, D. A., Twentyman, J., & Hunstad, D. A. (2017) · Infection and Immunity · doi:10.1128/iai.00647-17 · Cited by 24
Lin, J., Wu, C. A., Yan, C., Ou, Q., Lin, D., Zhou, J., Ye, X., & Yao, Z. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s157522 · Cited by 24
Delafloxacin: An Improved Fluoroquinolone Developed through Advanced Molecular Engineering
Bassetti, M., Righi, E., Pecori, D., & Tillotson, G. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0067 · Cited by 24
Nass, N. M., Farooque, S., Hind, C. K., Wand, M. E., Randall, C. P., Sutton, J. M., Seipke, R. F., Rayner, C. M., & O’Neill, A. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-17232-1 · Cited by 23
Odsbu, I., Khedkar, S., Khedkar, U., Nerkar, S., Tamhankar, A. J., & Lundborg, C. S. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15010153 · Cited by 23
Alfadli, M. N., El-Sehsah, E. M., & Ramadan, M. A.-M. (2018) · GERMS · doi:10.18683/germs.2018.1147 · Cited by 23
Antimicrobial Peptides: A Potential Therapeutic Option for Surgical Site Infections.
Deslouches, B., & Di, Y. P. (2017) · PubMed · Cited by 23
Sandison, T., Anda, C. S. D., Fang, E., Das, A., & Prokocimer, P. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02687-16 · Cited by 22
Schaumburg, F., Bletz, S., Mellmann, A., Becker, K., & Idelevich, E. A. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx253 · Cited by 22
Zouhir, A., Taieb, M., Ashraf, L. M., Cherif, A., Jridi, T., Mahjoubi, B., Mbarek, S., Fliss, I., Nefzi, A., Sebei, K., et al. (2016) · Archives of Microbiology · doi:10.1007/s00203-016-1293-6 · Cited by 21
One‐year safety and efficacy of tobramycin powder for inhalation in patients with cystic fibrosis
Konstan, M. W., Flume, P. A., Galeva, I., et al. (2015) · Pediatric Pulmonology · doi:10.1002/ppul.23358 · Cited by 20
Wang, K., Shin, E. P., Lee, H.-J., Jung, S.-J., Hwang, J.-W., Heo, I., Kim, J.-H., Oh, M., & Kim, Y.-R. (2018) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2018.04.037 · Cited by 20
Gillard, K., Miller, H. B., & Blackledge, M. S. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13361 · Cited by 20
Qiu, F., Li, M., Chen, J., Jin, H., & Jiang, L. (2016) · Medicinal Chemistry Research · doi:10.1007/s00044-016-1685-9 · Cited by 19
Self-citationThe Treatment of Possible Severe Infection in Infants
MOLYNEUX, E. M., Dube, Q., Banda, F. M., Chiume, M., Singini, I. L., Mallewa, M., Schwalbe, E. C., & Heyderman, R. S. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001576 · Cited by 19
Tseng, C., Tsai, Y.-H., Hu, A., Liou, J.-W., Chang, K., & Chang, H. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7654-x · Cited by 17
Selvadoss, P. P., Nellore, J., Ravindrran, M. B., & Sekar, U. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1408119 · Cited by 17
Zhou, Y., Feng, D.-Y., Li, W., Yang, H., Wang, Z.-N., Zhang, T., & Chen, Z. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s179181 · Cited by 16
Pourhajibagher, M., Kazemian, H., Chiniforush, N., & Bahador, A. (2017) · LASER THERAPY · doi:10.5978/islsm.17-or-7 · Cited by 15
Lytic Activity of Various Phage Cocktails on Multidrug-Resistant Bacteria
Ozkan, I., Akturk, E., Yeshenkulov, N., Atmaca, S., Rahmanov, N., & Atabay, H. I. (2016) · Clinical and investigative medicine · doi:10.25011/cim.v39i6.27504 · Cited by 14
Zhou, Q., He, B., Shen, N., Liang, Y., & Sun, L. (2017) · Drugs & Aging · doi:10.1007/s40266-016-0431-9 · Cited by 14
Wilson, T. J., Blackledge, M. S., & Vigueira, P. A. (2018) · Heliyon · doi:10.1016/j.heliyon.2017.e00501 · Cited by 14
Lin, J., & Yao, Z. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00384 · Cited by 14
Sabaeifard, P., Abdi-ali, A., Gamazo, C., Irache, J., & Soudi, M. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000430 · Cited by 13
Silver-containing nanoparticles in the research of new antimicrobial agents against ESKAPE pathogens
Borthagaray, G., Mondelli, M. A., Facchin, G., & Torre, M. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813661-4.00008-0 · Cited by 12
Universal fluorescent sensors of high-affinity iron transport, applied to ESKAPE pathogens
Chakravorty, S., Shipelskiy, Y., Kumar, A., Majumdar, A., Yang, T., Nairn, B. L., Newton, S. M., & Klebba, P. E. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006921 · Cited by 11
Elahi, A., Akya, A., Chegenelorestani, R., & Rezaee, M. (2018) · International Journal of Applied and Basic Medical Research · doi:10.4103/ijabmr.ijabmr_333_16 · Cited by 11
Onanuga, A., Omeje, M. C., & Eboh, D. D. (2018) · African Journal of Infectious Diseases · doi:10.21010/ajid.v12i2.3 · Cited by 11
Burr, S. E., Camara, B., Oluwalana, C., Bojang, E., Bottomley, C., Bojang, A., Bailey, R. L., D’Alessandro, U., & Roca, A. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2909-4 · Cited by 8
Björkhem‐Bergman, L., Missailidis, C., Valik, J. K., Tammelin, A., Ekström, L., Bottai, M., Hammar, U., Lindh, G., & Bergman, P. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3306-7 · Cited by 8
Dujowich, M., Case, J. B., Ellison, G. W., & Wellehan, J. F. X. (2016) · Photomedicine and Laser Surgery · doi:10.1089/pho.2016.4107 · Cited by 3
Cited by
Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections
Hu, X., Huang, Y.-Y., Wang, Y., Wang, X., & Hamblin, M. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01299 · Cited by 502
Advances in Antimicrobial Microneedle Patches for Combating Infections
Jamaledin, R., Yiu, C. K. Y., Zare, E. N., Niu, L., Vecchione, R., Chen, G., Gu, Z., Tay, F. R., & Makvandi, P. (2020) · Advanced Materials · doi:10.1002/adma.202002129 · Cited by 461
Self-citationOptimized arylomycins are a new class of Gram-negative antibiotics
Smith, P. A., Koehler, M. F. T., Girgis, H. S., Yan, D., Chen, Y., Chen, Y., Crawford, J. J., Durk, M. R., Higuchi, R. I., Kang, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0483-6 · Cited by 355
Liao, C., Huang, X., Wang, Q., Yao, D., & Lu, W. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.926758 · Cited by 309
Ferreira, R. L., da Silva, B. C. M., Rezende, G. S., Nakamura-Silva, R., Pitondo-Silva, A., Campanini, E. B., Brito, M. C. A., da Silva, E. M. L., Freire, C. C. D. M., Cunha, A. F. D., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03198 · Cited by 257
Metadata
- Authors
- Ma, Y., Wang, C., Li, Y., Li, J., Wan, Q., Chen, J., Tay, F. R., & Niu, L.
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2019-12-05
- Volume
- 7
- Issue
- 1
- Pages
- 1901872-1901872
- ISSN
- 2198-3844 (ISSN-L)
- OpenAlex
- W2992929975
- Cited by
- 314
- References
- 455
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.